INTERNATIONAL PATENT: ONCHILLES PHARMA, INC. FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITIONS COMPRISING PROTEIN COMPLEXES OF MODIFIED A2M OR A2ML"

GENEVA, April 13 -- ONCHILLES PHARMA, INC. (9880 Campus Point DriveSuite 420San Diego, California 92121) filed a patent application (PCT/IB2025/059915) for "PHARMACEUTICAL COMPOSITIONS COMPRISING PROTEIN COMPLEXES OF MODIFIED A2M OR A2ML" on Oct 02, 2025. With publication no. WO/2026/074475, the details related to the patent application was published on Apr 09, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BECKER, Lev (c/o Onchilles Pharma, Inc.9880 Campus Point DriveSuite 420San Diego, California 92121), CUI, Chang (c/o Onchilles Pharma, Inc.9880 Campus Point DriveSuite 420San Diego, Cali...